
Join to view full profile
3033 Science Park Road#300San Diego, CA 92121
Phone+1 858-925-5519
Dr. Aranda is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Gastroenterology, 1992 - 1995
Los Angeles County-Harbor-UCLA Medical CenterResidency, Internal Medicine, 1986 - 1989
Stanford University School of MedicineClass of 1986
Certifications & Licensure
CA State Medical License 1988 - 2027
American Board of Internal Medicine Internal Medicine
Clinical Trials
- GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH) Start of enrollment: 2020 Nov 12
Publications & Presentations
PubMed
- Editorial: protecting hypoxia-inducible factor 1a and gut integrity with GB004-a promising therapeutic approach for ulcerative colitis? Authors' reply.Silvio Danese, Barrett G Levesque, Brian G Feagan, Alina Jucov, B R Bhandari
Alimentary Pharmacology & Therapeutics. 2022-03-01 - 25 citationsRandomised clinical trial: a phase 1b study of GB004, an oral HIF-1α stabiliser, for treatment of ulcerative colitis.Silvio Danese, Barrett G Levesque, Brian G Feagan, Alina Jucov, Bal Raj Bhandari
Alimentary Pharmacology & Therapeutics. 2022-02-01 - 20 citationsChallenges and Opportunities in IBD Clinical Trial DesignMarla Dubinsky, Rory Collins, Maria T. Abreu, Vipul Jairath, James D. Lewis
Gastroenterology. 2021-04-20
Press Mentions
With GlaxoSmithKline in the Rearview Mirror, Abbas Hussain Is Ready to Lead a Biotech of His Own; Doug Treco Scores First CEO Job Since Ra Pharma BuyoutJune 25th, 2021
The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing DealJune 22nd, 2021
The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing DealJune 22nd, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: